Emerging prophylaxis strategies against COVID-19

Monaldi Arch Chest Dis. 2020 Mar 30;90(1). doi: 10.4081/monaldi.2020.1289.

Abstract

The Novel corona virus 2019 which started as an outbreak in China in December 2019 has rapidly spread all over the world, such that on 11th March 2020 WHO declared this disease as pandemic. The emergency that the world faces today demands that we develop urgent and effective measures to protect people at high risk of transmission. WHO has accelerated research in diagnostics, vaccines and therapeutics for this novel coronavirus.

Publication types

  • Review

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Betacoronavirus* / drug effects
  • Betacoronavirus* / immunology
  • Betacoronavirus* / pathogenicity
  • COVID-19
  • COVID-19 Drug Treatment
  • COVID-19 Vaccines
  • Chemoprevention
  • Chloroquine / therapeutic use*
  • Clinical Trials as Topic
  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / prevention & control
  • Humans
  • Hydroxychloroquine / therapeutic use*
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • SARS-CoV-2
  • Viral Vaccines / therapeutic use*

Substances

  • Antiviral Agents
  • COVID-19 Vaccines
  • Viral Vaccines
  • Hydroxychloroquine
  • Chloroquine